EMCOR Group, Inc.
754.29USD
-18.8700 (-2.44%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $8.33▲ | $7.5 | 8 | 0 |
| Next quarter | $8.63▲ | $7.82 | 8 | 0 |
| Current year | $32.85▲ | $29.33 | 8 | 0 |
| Next year | $36.75▲ | $32.67 | 9 | 0 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $7.23 | $9.06 | +1.83 (+25.3%) |
| 2026-03-31 | $5.9 | $6.84 | +0.94 (+15.8%) |
| 2025-12-31 | $6.68 | $7.19 | +0.51 (+7.6%) |
| 2025-09-30 | $6.53 | $6.57 | +0.04 (+0.7%) |
56 ratings from 13 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Maintained | Overweight | $1,123 $1,047 | Aug 10, 2026 |
| UBS | Maintained | Buy | $975 $1,065 | Jul 31, 2026 |
| Oppenheimer | Maintained | Outperform | $1,100 $1,200 | Jul 31, 2026 |
| Cantor Fitzgerald | Reiterated | Overweight | $1,123 | Jun 16, 2026 |
| Oppenheimer | Initiated | Outperform | $1,100 | May 28, 2026 |
| Cantor Fitzgerald | Initiated | Overweight | $848 | Mar 10, 2026 |
| UBS | Maintained | Buy | $900 $945 | Mar 6, 2026 |
| Stifel | Maintained | Buy | $754 $814 | Mar 3, 2026 |
| DA Davidson | Maintained | Buy | $800 $900 | Feb 27, 2026 |
| Baird | Maintained | Outperform | $713 $808 | Feb 27, 2026 |
| Stifel | Maintained | Buy | $713 $754 | Jan 26, 2026 |
| DA Davidson | Maintained | Buy | $725 $800 | Oct 31, 2025 |
| Stifel | Maintained | Buy | $692 $718 | Oct 13, 2025 |
| Goldman Sachs | Maintained | Neutral | $495 $675 | Oct 8, 2025 |
| William Blair | Initiated | Outperform | — | Sep 11, 2025 |
| DA Davidson | Maintained | Buy | $515 $725 | Aug 1, 2025 |
| UBS | Maintained | Buy | $570 $715 | Jul 25, 2025 |
| Stifel | Maintained | Buy | $503 $597 | Jul 11, 2025 |
| Goldman Sachs | Maintained | Sell | $384 $435 | Jul 8, 2025 |
| Baird | Initiated | Outperform | $560 | Jun 27, 2025 |
| UBS | Initiated | Buy | $570 | Jun 13, 2025 |
| Stifel | Maintained | Buy | $514 $503 | May 1, 2025 |
| Stifel | Maintained | Buy | $600 $514 | Feb 27, 2025 |
| Goldman Sachs | Initiated | Sell | $445 | Nov 22, 2024 |
| Stifel | Initiated | Buy | $600 | Nov 15, 2024 |
93 filings from 13 insiders · 17 buy / 6 sell over 6m
Officers and directors of EME, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| ALTMEYER JOHN WDirector | Grant | 3 | — | — | Jul 31, 2026 |
| NALBANDIAN JASON R.Chief Financial Officer | Grant | 4 | — | — | Jul 31, 2026 |
| LOWE CAROL PDirector | Sell | 950 | $844.50 | $802k | Jun 17, 2026 |
| ALTMEYER JOHN WDirector | Grant | 304 | — | — | Jun 4, 2026 |
| MCEVOY MICHAEL KEVINDirector | Grant | 230 | — | — | Jun 4, 2026 |
| SCHWARZWAELDER STEVENDirector | Grant | 230 | — | — | Jun 4, 2026 |
| ROCHE PATRICK JDirector | Grant | 304 | — | — | Jun 4, 2026 |
| DAHL AMY EDirector | Grant | 230 | — | — | Jun 4, 2026 |
| WALKER-LEE ROBIN ADirector | Grant | 230 | — | — | Jun 4, 2026 |
| JOHNSON RONALD LDirector | Grant | 230 | — | — | Jun 4, 2026 |
| LOWE CAROL PDirector | Grant | 304 | — | — | Jun 4, 2026 |
| REID WILLIAM PDirector | Sell | 2.0k | $925.78 | $1.85M | May 11, 2026 |
| ALTMEYER JOHN WDirector | Sell | 2.5k | $895.00 | $2.24M | May 1, 2026 |
| SCHWARZWAELDER STEVENDirector | Sell | 5.6k | $895.19 | $5.01M | Apr 30, 2026 |
| NALBANDIAN JASON R.Chief Financial Officer | Sell | 800 | $856.43 | $685k | Apr 30, 2026 |
| LIND ROBERT PETEROfficer | Sell | 675 | $894.27 | $604k | Apr 30, 2026 |
| GUZZI ANTHONY JChief Executive Officer | Gift | 3.0k | — | — | Apr 30, 2026 |
| ALTMEYER JOHN WDirector | Grant | 2 | — | — | Apr 30, 2026 |
| REID WILLIAM PDirector | Grant | 1 | — | — | Apr 30, 2026 |
| GUZZI ANTHONY JChief Executive Officer | Grant | 13 | — | — | Apr 30, 2026 |
No analyst notes on EME yet.
Analyst Ratings
7 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 7 | 3 | 0 | 0 | Buy2.30 |
| 1 mo ago | 0 | 7 | 3 | 0 | 0 | Buy2.30 |
| 2 mo ago | 0 | 7 | 3 | 0 | 0 | Buy2.30 |